MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-13-2025
Vaxart ROE Ratio 2011-2026 | VXRT
Annual ROE Ratio Vaxart
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -142.66 | -97.43 | -37.58 | -0.03 | -143.95 | -160.23 | -157.22 | -54.98 | -27.48 | -12.66 | -12.76 | - | -7.7 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -0.03 | -160.23 | -71.22 |
Quarterly ROE Ratio Vaxart
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -130.76 | -120.9 | -95.9 | -85.0 | -109.32 | -113.08 | -119.01 | -78.85 | -102.81 | -102.44 | -96.5 | -59.62 | -70.69 | -55.31 | -42.81 | -36.8 | -36.96 | -34.93 | -34.14 | -26.11 | -64.36 | -98.42 | -134.67 | -143.95 | -138.2 | -155.85 | -191.27 | -160.34 | -113.84 | -49.96 | 37.76 | 30.86 | 58.78 | 25.85 | -15.43 | -50.77 | -92.77 | -75.84 | -52.7 | -40.55 | -21.35 | -19.82 | -2.99 | -1.43 | -9.47 | -6.63 | -14.25 | -12.03 | -6.05 | -24.07 | -15.78 | -13.49 | -29.78 | -5.62 | -21.58 | -14.79 | 0.13 | -7.81 | 3.36 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 58.78 | -191.27 | -54.25 |
ROE Ratio of other stocks in the Biotechnology industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
ACADIA Pharmaceuticals
ACAD
|
30.9 | $ 22.5 | 1.86 % | $ 3.73 B |  USA |
 |
MorphoSys AG
MOR
|
15.76 | - | 2.43 % | $ 254 M |  Germany |
 |
Acorda Therapeutics
ACOR
|
160.08 | - | -24.86 % | $ 820 K | USA |
 |
Adverum Biotechnologies
ADVM
|
-185.15 | - | - | $ 86.2 M | USA |
 |
AlloVir
ALVR
|
-55.11 | - | 4.14 % | $ 49.1 M | USA |
 |
Alnylam Pharmaceuticals
ALNY
|
39.76 | $ 327.16 | 2.39 % | $ 42.9 B | USA |
 |
Applied Molecular Transport
AMTI
|
-207.64 | - | - | $ 10.1 M | USA |
 |
Amgen
AMGN
|
89.06 | $ 349.22 | 2.71 % | $ 188 B | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
12.44 | $ 20.4 | -0.87 % | $ 954 M | USA |
 |
Applied Therapeutics
APLT
|
698.49 | - | - | $ 8.42 M | USA |
 |
I-Mab
IMAB
|
-85.31 | - | - | $ 866 M |  China |
 |
Aquestive Therapeutics
AQST
|
248.9 | $ 4.18 | 1.33 % | $ 447 M | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
5.18 | - | - | $ 40.3 B | USA |
 |
Genfit SA
GNFT
|
626.29 | - | 2.54 % | $ 160 B |  France |
 |
Arcutis Biotherapeutics
ARQT
|
-8.52 | $ 24.57 | 5.59 % | $ 3.13 B | USA |
 |
Biophytis SA
BPTS
|
-751.94 | - | -13.47 % | $ 169 M | France |
 |
AVROBIO
AVRO
|
12.83 | - | 1083.1 % | $ 745 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
3458.87 | - | - | $ 7.46 M |  Israel |
 |
AstraZeneca PLC
AZN
|
20.44 | - | - | $ 96.9 B |  Britain |
 |
Midatech Pharma plc
MTP
|
-330.29 | - | -18.52 % | $ 27.3 M | Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-115.61 | - | -1.52 % | $ 24.7 M | USA |
 |
Autolus Therapeutics plc
AUTL
|
-161.42 | $ 1.48 | 8.46 % | $ 394 M | Britain |
 |
BeiGene, Ltd.
BGNE
|
6.58 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Alterity Therapeutics Limited
ATHE
|
-36.22 | $ 3.85 | 2.41 % | $ 9.26 B |  Australia |
 |
BioNTech SE
BNTX
|
1.11 | $ 91.76 | 2.39 % | $ 27.2 B | Germany |
 |
CymaBay Therapeutics
CBAY
|
-36.05 | - | - | $ 3.45 B | USA |
 |
Advaxis
ADXS
|
196.88 | - | -9.65 % | $ 45.9 M | USA |
 |
Aytu BioScience
AYTU
|
-71.51 | $ 2.71 | 5.51 % | $ 17 M | USA |
 |
Avid Bioservices
CDMO
|
-231.16 | - | - | $ 789 M | USA |
 |
Cidara Therapeutics
CDTX
|
-103.99 | - | - | $ 1.41 B | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
-144.96 | $ 3.06 | 0.99 % | $ 6.66 B | Israel |
 |
Институт стволовых клеток человека
ISKJ
|
17.55 | - | - | - |  Russia |
 |
Cabaletta Bio
CABA
|
-149.8 | $ 3.06 | -0.33 % | $ 307 M | USA |
 |
Checkpoint Therapeutics
CKPT
|
445.47 | - | - | $ 169 M | USA |
 |
Cerus Corporation
CERS
|
-24.33 | $ 1.9 | 2.99 % | $ 362 M | USA |
 |
Coherus BioSciences
CHRS
|
275.39 | $ 1.7 | 1.8 % | $ 199 M | USA |
 |
CollPlant Biotechnologies Ltd.
CLGN
|
-123.35 | $ 0.36 | 0.28 % | $ 4.12 M | Israel |
 |
Aeterna Zentaris
AEZS
|
-401.79 | - | 5.93 % | $ 314 M |  Canada |
 |
Checkmate Pharmaceuticals
CMPI
|
-88.4 | - | - | $ 231 M | USA |
 |
AgeX Therapeutics
AGE
|
51843.24 | - | -10.17 % | $ 12.2 K | USA |
 |
Concert Pharmaceuticals
CNCE
|
-71.33 | - | - | $ 401 M | USA |
 |
Aeglea BioTherapeutics
AGLE
|
-21.7 | - | - | $ 1.01 B | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
-62.37 | - | - | $ 26.5 M | USA |
 |
Catalyst Pharmaceuticals
CPRX
|
22.46 | $ 25.57 | 2.3 % | $ 3.13 B | USA |
 |
CTI BioPharma Corp.
CTIC
|
529.06 | - | - | $ 1.2 B | USA |
 |
AIkido Pharma
AIKI
|
-32.34 | - | 1.93 % | $ 17.4 M | USA |
 |
Aptose Biosciences
APTO
|
93.75 | - | -45.71 % | $ 1.2 M | Canada |
 |
Cyclacel Pharmaceuticals
CYCCP
|
-43.82 | - | -4.36 % | $ 27 M | USA |
 |
Cellectar Biosciences
CLRB
|
-255.25 | $ 2.81 | 2.18 % | $ 7.33 M | USA |
 |
Deciphera Pharmaceuticals
DCPH
|
-55.55 | - | - | $ 2.18 B | USA |